Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin PD Effects in Healthy Males
NCT06600607Phase 1Completed
- Sponsor
- Latigo Biotherapeutics
- Start
- Oct 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pregabalin in pain (2 arms), sponsored by Latigo Biotherapeutics. Primary endpoints: Change from baseline pain score after dosing with pregabalin vs. placebo, Time to reach Pain Detection Threshold (PDT) after dosing and 1 more. Started Oct 2024; status: completed.
02
Drugs
pregabalin
03
Conditions
pain
Beyond the preview
Go deeper on NCT06600607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06600607.